NCT00505973已完成1 期
An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese Male Subjects
Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2007年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Adverse events, safety laboratory results, vital signs, and ECGs will be used to monitor subject safety.
研究概览
简要总结
This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healty Japanese men willing to use a medically acceptable form of contraception.
排除标准
- •Any significant disease
- •Positive urine drug screen
- •Increased liver function tests
- •Use of prescription drugs.
结局指标
主要结局
Adverse events, safety laboratory results, vital signs, and ECGs will be used to monitor subject safety.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female SubjectsSchizophreniaNCT00458107Wyeth is now a wholly owned subsidiary of Pfizer64
已完成
1 期
Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese MenHealthyNCT00385190Wyeth is now a wholly owned subsidiary of Pfizer24
已完成
1 期
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With SchizophreniaSchizophreniaNCT02720263Astellas Pharma Global Development, Inc.48
已完成
1 期
Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 DaysHealthyNCT00791388Procter and Gamble45
已完成
1 期
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male SubjectsDiabetes MellitusNCT00448032Wyeth is now a wholly owned subsidiary of Pfizer